Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary

被引:0
作者
Sherman, Elizabeth M. [1 ,2 ]
Agwu, Allison L. [3 ]
Ambrosioni, Juan [4 ,5 ,6 ,7 ,8 ]
Behrens, Georg M. N. [9 ,10 ,11 ]
Chu, Carolyn [12 ]
Collins, Lauren F. [13 ]
Jimenez, Humberto R. [14 ,15 ]
Koren, David E. [16 ]
McGorman, Leslie [17 ,28 ]
Nguyen, Nancy N. [18 ]
Nicol, Melanie R. [19 ]
Pandit, Neha Sheth [20 ]
Pierre, Natacha [21 ]
Scarsi, Kimberly K. [22 ]
Spinner, Gary F. [23 ]
Tseng, Alice [24 ,25 ]
Young, Jeremy D. [26 ]
Badowski, Melissa E. [27 ]
机构
[1] Nova Southeastern Univ, Barry & Judy Silverman Coll Pharm, Ft Lauderdale, FL 33328 USA
[2] Mem Healthcare Syst, Div Infect Dis, Hollywood, FL USA
[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD USA
[4] Hosp Clin Barcelona, HIV Unit, Barcelona, Spain
[5] Hosp Clin Barcelona, Infect Dis Serv, Barcelona, Spain
[6] Fundacio Recerca Clin Barcelona IDIBAPS, Barcelona, Spain
[7] Univ Barcelona, Barcelona, Spain
[8] Inst Salud Carlos III, CIBERINFEC, Madrid, Spain
[9] Hannover Med Sch, Dept Rheumatol & Immunol, Hannover, Germany
[10] German Ctr Infect Res DZ, Partner Site Hannover Braunschweig, Hannover, Germany
[11] Hannover Med Sch, Ctr Individualized Infect Med CiiM, Hannover, Germany
[12] Univ Calif San Francisco, San Francisco, CA USA
[13] Grady Ponce de Leon Ctr, Emory Sch Med, Div Infect Dis, Atlanta, GA USA
[14] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ USA
[15] St Josephs Univ, Comprehens Care Ctr, Med Ctr, Paterson, NJ USA
[16] Temple Univ Hlth Syst, Philadelphia, PA USA
[17] Amer Acad HIV Med, Washington, DC USA
[18] Univ Pacific, Thomas J Long Sch Pharm, Stockton, CA USA
[19] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN USA
[20] Univ Maryland Baltimore, Sch Pharm, Dept Practice Sci & Hlth Outcomes Res, Baltimore, MD USA
[21] Univ Illinois, Coll Nursing, Dept Populat Hlth Nursing Sci, Chicago, IL USA
[22] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice & Sci, Omaha, NE USA
[23] Southwest Community Hlth Ctr, Bridgeport, CT USA
[24] Univ Hlth Network, Immunodeficiency Clin, Toronto, ON, Canada
[25] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[26] Ohio State Univ, Wexner Med Ctr, Div Infect Dis, Columbus, OH USA
[27] Univ Illinois, Coll Pharm, Chicago, IL USA
[28] AIDS United, Washington, DC USA
来源
PHARMACOTHERAPY | 2024年 / 44卷 / 07期
关键词
antiretrovirals; HIV; long acting; pre-exposure prophylaxis; prevention; treatment; ANTITUMOR NECROSIS FACTOR; SERIOUS BACTERIAL-INFECTIONS; PROPENSITY SCORE METHODS; RHEUMATOID-ARTHRITIS; RISK; HOSPITALIZATION; THERAPY; SURVIVAL;
D O I
10.1002/phar.2921
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Five long-acting (LA) antiretrovirals (ARVs) are currently available in a limited number of countries worldwide for HIV-1 prevention or treatment - cabotegravir, rilpivirine, lenacapavir, ibalizumab, and dapivirine. Implementing use of LA ARVs in routine clinical practice requires significant changes to the current framework of HIV-1 prevention, treatment, and service provision. Given the novelty, complexity, and interdisciplinary requirements of safe and optimal use of LA ARVs, consensus recommendations on the use of LA ARVs will assist clinicians in optimizing use of these agents. The purpose of these recommendations is to provide guidance for the clinical use of LA ARVs for HIV-1 treatment and prevention. In addition, future areas of research are identified and discussed.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 44 条
[1]   Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database [J].
Atsumi, Tatsuya ;
Ando, Yoshiaki ;
Matsuda, Shinichi ;
Tomizawa, Shiho ;
Tanaka, Riwa ;
Takagi, Nobuhiro ;
Nakasone, Ayako .
MODERN RHEUMATOLOGY, 2018, 28 (03) :435-443
[2]   High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis [J].
Au, Karen ;
Reed, George ;
Curtis, Jeffrey R. ;
Kremer, Joel M. ;
Greenberg, Jeffrey D. ;
Strand, Vibeke ;
Furst, Daniel E. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (05) :785-791
[3]   Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis [J].
Austin, Peter C. .
STATISTICS IN MEDICINE, 2016, 35 (30) :5642-5655
[4]   The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments [J].
Austin, Peter C. .
STATISTICS IN MEDICINE, 2014, 33 (07) :1242-1258
[5]   A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality [J].
Austin, Peter C. .
MULTIVARIATE BEHAVIORAL RESEARCH, 2011, 46 (01) :119-151
[6]   Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research [J].
Austin, Peter C. .
COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2009, 38 (06) :1228-1234
[7]   Adverse reactions to biologic agents and their medical management [J].
Boyman, Onur ;
Comte, Denis ;
Spertini, Francois .
NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (10) :612-627
[8]  
Carrara G, 2019, CLIN EXP RHEUMATOL, V37, P60
[9]   Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis [J].
Chen, Ying-Chou ;
Lin, Wei-Che .
PLOS ONE, 2017, 12 (08)
[10]   Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis [J].
Dixon, William G. ;
Abrahamowicz, Michal ;
Beauchamp, Marie-Eve ;
Ray, David W. ;
Bernatsky, Sasha ;
Suissa, Samy ;
Sylvestre, Marie-Pierre .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (07) :1128-1133